Wildfire Smoke Dents Survival Odds For Lung Cancer Patients

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

MONDAY, June 2, 2025 — Wildfire smoke could make it harder for people with lung cancer to survive, a new study says.

Californians with lung cancer who breathed smoke from wildfires had a 20% increased risk of dying from their cancer, researchers reported Saturday at the American Society of Clinical Oncology’s (ASCO) annual meeting in Chicago.

Wildfire smoke contains particle pollution that can get deep into the lungs, noted researcher Dr. Surbhi Singhal, an assistant professor of oncology at the University of California-Davis Comprehensive Cancer Center.

“The research tells us that there are small particles in the air that could make lung cancer worse,” Singhal said in an ASCO news release.

Researchers tracked more than 18,000 Californians with the most common kind of lung cancer — non-small cell lung cancer — between 2017 and 2020.

They estimated people’s exposure to wildfire smoke using air quality monitoring based on their home address.

Results showed that people with advanced stage 4 cancer who’d never smoked were most affected by wildfire air pollution. Their risk of dying from cancer rose 55% if they were exposed to lots of wildfire smoke.

"As wildfires become more frequent and intense in California and other parts of the U.S., we need targeted health strategies to protect cancer patients and others with serious health problems,” Singhal said. “These results highlight the urgent need to protect vulnerable populations living in wildfire-prone regions.”

Interestingly, stage 4 lung cancer patients with a history of smoking who were being treated with immunotherapy actually experienced better survival rates during days of extremely high particle pollution levels from wildfires, researchers found.

They said this suggests that smoke-related changes in the body might interact with certain treatments, and should be studied further.

Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.

Sources

  • University of California-Davis, news release, May 31, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-06-03 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords